Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression.

Nature communications·2026
Same author

Hedgehog Inhibitor and Paclitaxel: A Phase I Trial of the Oral Hedgehog inhibitor Taladegib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumours.

Investigational new drugs·2026
Same author

Tissue-trained fibroblasts fuel invasion with lipids.

Nature metabolism·2026
Same author

β-tubulin phosphorylation by Chk1 is required for normal spindle formation during cell division.

Communications biology·2026
Same author

Vγ1 γδ T cells steer airway macrophages toward a profibrotic response in an autochthonous lung cancer mouse model.

Science advances·2026
Same author

Functionally dominant hotspot mutations of mitochondrial ribosomal RNA genes in cancer.

Nature genetics·2025
Same journal

Tunable self-assembling cellular microarray for single-neutrophil vital and suicidal extracellular traps.

Lab on a chip·2026
Same journal

Precise programmable tumor cell subpopulation sorting <i>via</i> an electromagnetic microfluidic platform.

Lab on a chip·2026
Same journal

Bridging dimensions: combining one- and two-photon 3D printing for microfluidic device fabrication.

Lab on a chip·2026
Same journal

Microfluidic rare cell analysis beyond counting: workflow design from enrichment to multi-omics.

Lab on a chip·2026
Same journal

A sperm racetrack to separate sperm by swim speed.

Lab on a chip·2026
Same journal

Controlled encapsulation and droplet size prediction in two-step microfluidic double emulsions.

Lab on a chip·2026
See all related articles

Related Experiment Video

Updated: Nov 3, 2025

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.0K

Microfluidic technologies for immunotherapy studies on solid tumours.

K Paterson1, S Zanivan2, R Glasspool3

  • 1Centre for Microsystems and Photonics, EEE Department, University of Strathclyde, Glasgow, UK. michele.zagnoni@strath.ac.uk.

Lab on a Chip
|June 4, 2021
PubMed
Summary
This summary is machine-generated.

Microfluidic technologies offer advanced in vitro models for studying immunotherapy in solid tumors. These models better mimic the tumor microenvironment (TME), improving the prediction of immunotherapy efficacy.

More Related Videos

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.2K
Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

11.7K

Related Experiment Videos

Last Updated: Nov 3, 2025

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.0K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.2K
Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

11.7K

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Immunotherapy shows promise for cancer treatment, particularly in hematological malignancies and melanoma.
  • Solid tumors present challenges due to the immunosuppressive tumor microenvironment (TME).
  • Current preclinical models (2D cultures, xenografts) inadequately replicate the human TME, limiting translational value.

Purpose of the Study:

  • To review immunotherapy concepts and current preclinical models for solid tumors.
  • To highlight challenges in solid tumor immunotherapy research.
  • To explore microfluidic technologies as improved preclinical tools for immunotherapy in solid tumors.

Main Methods:

  • Review of immunotherapy principles and existing preclinical models.
  • Discussion of limitations in current in vitro and in vivo models.
  • Exploration of microfluidic and lab-on-a-chip technologies for TME and immunotherapy studies.

Main Results:

  • Microfluidics enables mechanistic studies of the TME and immunotherapy.
  • Microfluidic platforms can enhance experimental throughput with patient-derived tissues.
  • These technologies offer more faithful recapitulation of human solid tumors for testing immunotherapies.

Conclusions:

  • Microfluidic technologies represent a significant advancement for preclinical immunotherapy research in solid tumors.
  • These platforms can improve the understanding of cancer-immune cell interactions within the TME.
  • Further development and incorporation of microfluidics are crucial for future immunotherapy studies.